135 related articles for article (PubMed ID: 18240093)
1. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA.
Lee RJ
IDrugs; 2008 Feb; 11(2):101-4. PubMed ID: 18240093
[No Abstract] [Full Text] [Related]
2. Ocular Diseases & Drug Discovery--GTCbio's Inaugural Conference. 20-21 April 2009, Philadelphia, PA, USA.
Boniuk V
IDrugs; 2009 Jun; 12(6):346-8. PubMed ID: 19517312
[No Abstract] [Full Text] [Related]
3. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
Seneci P
IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
[No Abstract] [Full Text] [Related]
4. Reality check for device-drug convergence.
Ratner M
Nat Biotechnol; 2007 Feb; 25(2):157-9. PubMed ID: 17287739
[No Abstract] [Full Text] [Related]
5. Big pharmas seek biotechs that deliver.
Dove A
Nat Biotechnol; 2001 May; 19(5):398. PubMed ID: 11328985
[No Abstract] [Full Text] [Related]
6. Is personalized medicine finally arriving?
Allison M
Nat Biotechnol; 2008 May; 26(5):509-17. PubMed ID: 18464779
[TBL] [Abstract][Full Text] [Related]
7. Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference. October 20-22, 2010, San Francisco, CA, USA.
Garren H
IDrugs; 2010 Dec; 13(12):840-2. PubMed ID: 21154139
[TBL] [Abstract][Full Text] [Related]
8. Cytokines & inflammation--GTCbio's seventh annual conference. 29-30 January 2009, San Diego, CA, USA.
Fricker S
IDrugs; 2009 Apr; 12(4):214-6. PubMed ID: 19350461
[No Abstract] [Full Text] [Related]
9. Biopharmaceuticals: recent approvals and likely directions.
Walsh G
Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Diseases World Summit 2005. Partnering and deal-making. 29 June-1 July 2005, San Francisco, CA, USA.
Clark AG
IDrugs; 2005 Sep; 8(9):708-9. PubMed ID: 16118687
[No Abstract] [Full Text] [Related]
11. American Association of Pharmaceutical Scientists--annual meeting and exposition: drug discovery and development. 15-19 November 1998, San Francisco, CA, USA.
Chamberlain J
IDrugs; 1999 Jan; 2(1):26-8. PubMed ID: 16180164
[TBL] [Abstract][Full Text] [Related]
12. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
Brown D
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C: staying the course.
Garber K
Nat Biotechnol; 2007 Dec; 25(12):1379-81. PubMed ID: 18066031
[No Abstract] [Full Text] [Related]
14. The long march of antisense.
Jones D
Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
[No Abstract] [Full Text] [Related]
15. Target Discovery--Select Biosciences' World Congress. 4-5 August 2009, San Francisco, CA, USA.
Fernández A
IDrugs; 2009 Oct; 12(10):620-2. PubMed ID: 19790009
[TBL] [Abstract][Full Text] [Related]
16. The 14th International Symposium on Recent Advances in Drug Delivery Systems, February 15-18, 2009, Salt Lake City, UT, USA.
Park K; Bae YH; Grainger DW
J Control Release; 2009 Dec; 140(3):183-4. PubMed ID: 19751779
[No Abstract] [Full Text] [Related]
17. Inhibitex, Inc: antibody anti-infectives.
McCarthy AA
Chem Biol; 2005 Mar; 12(3):257-9. PubMed ID: 15797206
[No Abstract] [Full Text] [Related]
18. Deal watch: microRNA collaboration to target cardiovascular disease pathways.
Nat Rev Drug Discov; 2011 Dec; 10(12):890. PubMed ID: 22129979
[No Abstract] [Full Text] [Related]
19. Targeted drug therapy remains a challenge.
Traynor K
Am J Health Syst Pharm; 2011 Dec; 68(24):2320-4. PubMed ID: 22135055
[No Abstract] [Full Text] [Related]
20. Jay Bradner.
Nat Rev Drug Discov; 2017 Mar; 16(4):232-233. PubMed ID: 28356589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
